Artificial Intelligence

Artificial Intelligence, Healthcare & The Fourth Industrial Revolution

Artificial Intelligence, Healthcare & The Fourth Industrial Revolution

This post is hosted on the Huffington Post's Contributor platform. Contributors control their own work and post freely to our site. If you need to flag this entry as abusive, send us an email

The role of Artificial Intelligence (AI) as a major catalyst in the healthcare revolution is unquestionable. We are today experiencing the Fourth Industrial Revolution, and the proliferation of technologies that are fusing the physical, digital and biological worlds and thereby impacting global economies and industries is unparalleled.

While we are seeing the pervasive influence of technology in our lifestyle, we are challenged by the burden of chronic disease on our healthcare system. In the United States chronic disease accounts for $3 of every $4 spent on healthcare or $7,900 for every American with chronic disease. Chronic disease causes 7 out of every 10 deaths. Chronic disease is both predictable and preventable, and AI can play a pivotal role in addressing solutions that can provide personalized medicine, and interventions.

Read Also:
Automating automation: Machine learning behind the curtain

Big Data, Deep Learning & Disease Detection – AI has already started revolutionizing the healthcare by leveraging big data analysis to optimize healthcare services. A good example of this service is Google’s Deepmind Health project. IBM Watson for Oncology has an advanced ability to analyze a patient’s data and provide personalized treatment plans that combines the attributes from the patient’s file, clinical expertise, external research and data. These techniques can be also leveraged to detect cancer or vascular diseases in their very early stage.

Precision Medicine & Deep Genomics – Identifying patterns in huge data sets of genetic information and medical records, looking for mutations and linkages in diseases and personalizing the treatment and process protocols for a patient will play a key role in increasing the efficacy of treatment to address chronic disease. Atomwise has launched a virtual search for safe, existing medicines that could be redesigned to treat the Ebola virus. Similarly, nearly 50% of the U.S. population, and almost 90% of people 65 years and over (or approximately 36 million patients), take at least one prescription drug and more than 10% of the U.S. population, and almost 40% of people 65 years and over (or approximately 16 million patients), take five or more prescription drugs. We can leverage AI to address the huge burden on the healthcare system by polypharmacy.

Read Also:
Manufacturing Business Intelligence


Read Also:
This chief data officer is breaking down silos, one at a time
Read Also:
What humans need to learn about machine learning
Big Data Innovation Summit London
30 Mar
Big Data Innovation Summit London

$200 off with code DATA200

Read Also:
Why Social Media Analytics Cannot Rely On Machine Learning
Read Also:
Using AI, Microsoft hopes to treat blindness

Leave a Reply

Your email address will not be published. Required fields are marked *